Viewing Study NCT05510466

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:43 PM
Ignite Modification Date: 2026-02-03 @ 9:11 AM
Study NCT ID: NCT05510466
Status: UNKNOWN
Last Update Posted: 2022-08-22
First Post: 2022-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Triple BRAFinh/MEKinh /antiPD1 Combined Therapy in Patients With BRAF Mutated Melanoma With Central Nervous System Metastasis
Sponsor: University Hospital, Montpellier
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Initially treated by a doubled targeted therapy anti BRAF/anti MEK View
None immunotherapy View
None combined tritherapy View
None melanoma's brain metastasis View
None With an intra cerebral progression of the tumor View